Our people

Susie Harrison

Susie Harrison

Our People

Susie Harrison

IP Director, Patent Attorney

Life Sciences

Cambridge

Our People

Our IP specialists work at all stages of the IP life cycle and provide strategic advice about patent, trade mark and registered designs, as well as any IP-related disputes and legal and commercial requirements.

View the team

News & Insights

We want to keep you up to date with developments in the IP world and let you know what we are up to at Mewburn Ellis.

Learn more

Law & Practice Guide

We believe in making it easy for you to find the information that you want – and you can always contact us if you can’t find what you need

Read our law and practice guides

Blogs by Author

All posts

Susie spends most of her time carrying out patent prosecutions before the European Patent Office in the life sciences sector. She also has experience in worldwide prosecution, as well as EPO opposition and appeal proceedings.

Areas of Expertise

  • Personal medicine/diagnostic and prognostic markers
  • Nucleic acid and protein therapeutics/diagnostics
  • Nucleic acid editing using CRISPR/Cas 9 technologies
  • Antibody engineering
  • Foetal DNA analysis techniques
  • Culture media

Clients

Susie works predominantly with life sciences attorney firms in the US, Japan and Australia, as well as small and large life sciences companies in the US and Europe and technology transfer organisations.

Background

Susie has a biochemistry degree from the University of Newcastle-Upon-Tyne. She trained in the patent department of an international pharmaceutical company in Switzerland from 1986 to 1990, also working for a large firm of patent attorneys in London from 1990 to 1994. She qualified as a Chartered Patent Attorney in 1991 and a European Patent Attorney the following year, joining Mewburn Ellis LLP in 2001. Susie became a Patent Director with the introduction of that role to Mewburn Ellis LLP.

Recommendations

Susie has been listed as a recommended lawyer and key lawyer in the 2022 edition of The Legal 500.